Your browser doesn't support javascript.
loading
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones, Kathy; Bergeron, Christophe; de Camargo, Beatriz; van den Heuvel-Eibrink, Marry M; Acha, Tomas; Godzinski, Jan; Oldenburger, Foppe; Boccon-Gibod, Liliane; Leuschner, Ivo; Vujanic, Gordan; Sandstedt, Bengt; de Kraker, Jan; van Tinteren, Harm; Graf, Norbert.
Afiliação
  • Pritchard-Jones K; Cancer Section, University College London Institute of Child Health, London, UK. Electronic address: k.pritchard-jones@ucl.ac.uk.
  • Bergeron C; Department of Paediatric Haemato-Oncology, Centre Léon Bérard, Lyon, France.
  • de Camargo B; Paediatric Haemato-Oncology Program, Research Center, Instituto Nacional do Cancer, Rio de Janeiro, Brazil.
  • van den Heuvel-Eibrink MM; Princess Màxima Center for Paediatric Oncology, Utrecht, Netherlands.
  • Acha T; Unidad de Oncología Pediátrica, Hospital Materno-Infantil Carlos Haya, Malaga, Spain.
  • Godzinski J; Department of Paediatric Surgery, Marciniak Hospital, Wroclaw, Poland.
  • Oldenburger F; Department of Radiotherapy, Academic Medical Centre, Amsterdam, Netherlands.
  • Boccon-Gibod L; Department of Paediatric Pathology, University Hopital Armand Trousseau, Paris, France.
  • Leuschner I; Kiel Paediatric Tumour Registry, Department of Paediatric Pathology, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Vujanic G; Department of Paediatric Pathology, Institute of Cancer & Genetics, Cardiff University, Cardiff, UK.
  • Sandstedt B; Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, Sweden.
  • de Kraker J; Department of Pediatric Haemato-Oncology, Academic Medical Centre, Amsterdam, Netherlands.
  • van Tinteren H; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Graf N; Department of Paediatric Haemato-Oncology, University of Saarland, Homburg, Germany.
Lancet ; 386(9999): 1156-64, 2015 Sep 19.
Article em En | MEDLINE | ID: mdl-26164096
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Tumor de Wilms / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Tumor de Wilms / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article